Markus C Stühlinger Selected Research

Atrial Fibrillation

2/2020

Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus C Stühlinger Research Topics

Disease

1	Atrial Fibrillation 02/2020
1	Neoplasms (Cancer) 02/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2020
1	Atrioventricular Block 09/2011
1	Tachycardia (Tachyarrhythmias) 09/2011
1	Reperfusion Injury 07/2007
1	Myocardial Reperfusion Injury 07/2007
1	Hyperplasia 08/2005
1	Myocardial Infarction 03/2005
1	Unstable Angina 03/2005
1	Atherosclerosis 03/2005
1	Acute Coronary Syndrome 03/2005
1	Hyperlipidemias (Hyperlipidemia) 02/2005
1	Vascular Diseases (Vascular Disease) 02/2005
1	Body Weight (Weight, Body) 08/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2002
1	Hypertension (High Blood Pressure) 03/2002
1	Insulin Resistance 03/2002
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2002

Drug/Important Bio-Agent (IBA)

3	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 07/2007 - 03/2002
2	Arginine (L-Arginine)FDA Link 07/2007 - 02/2005
2	HomocysteineIBA 08/2005 - 02/2005
1	ibrutinibIBA 02/2020
1	Phenobarbital (Luminal)FDA Link 08/2005
1	Methionine (L-Methionine)FDA Link 08/2003
1	Insulin (Novolin)FDA Link 03/2002
1	HDL CholesterolIBA 03/2002
1	LDL CholesterolIBA 03/2002
1	Rosiglitazone (Avandia)FDA Link 03/2002
1	Triglycerides (Triacylglycerol)IBA 03/2002
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2002
1	Glucose (Dextrose)FDA LinkGeneric 03/2002

Therapy/Procedure

1	Radiofrequency Ablation 09/2011
1	Therapeutics 09/2011
1	Carotid Endarterectomy 08/2005